| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Cardinal Health (NYSE: CAH) has been recognized by Forbes as one of America's Best Large Employers 2022, a list of more than 500 public and private corporations, hospitals, universities and more,...
Read more about Cardinal Health named one of America's Best Large Employers 2022 by Forbes magazine
Cardinal Health (NYSE: CAH) today announced it will leverage the Kinaxis® RapidResponse® platform to increase medical product visibility and supply chain agility. Kinaxis will enhance Cardinal...
Read more about Cardinal Health partners with Kinaxis to optimize digital supply chain planning
Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on April 15, 2022 to shareholders of record...
Read more about Cardinal Health Board of Directors Approves Quarterly Dividend
Today Cardinal Health published its 2022 Biosimilars Report: The U.S. Journey and Path Ahead, a publication that brings together the latest industry data on biosimilar utilization and payer...
Read more about Cardinal Health Predicts 2022 to be Turning Point for Biosimilars in the U.S.
Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2022 revenues of $45.5 billion, an increase of 9% from the second quarter of last year. Second quarter GAAP operating loss was...
Read more about Cardinal Health Reports Second Quarter Fiscal 2022 Results